Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring, and efficacy

Research output: Contribution to journalArticle

23 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)315-324
Number of pages10
JournalSeminars in Nephrology
Volume12
Issue number4
StatePublished - 1992

Fingerprint

Immunologic Monitoring
Antilymphocyte Serum
Graft Rejection
Immunosuppressive Agents
Immunosuppression
Allografts
T-Lymphocytes

ASJC Scopus subject areas

  • Nephrology

Cite this

@article{e44e75af6a8d4b65a2d2f4223c77d0f6,
title = "Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring, and efficacy",
author = "Douglas Norman",
year = "1992",
language = "English (US)",
volume = "12",
pages = "315--324",
journal = "Seminars in Nephrology",
issn = "0270-9295",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Antilymphocyte antibodies in the treatment of allograft rejection

T2 - targets, mechanisms of action, monitoring, and efficacy

AU - Norman, Douglas

PY - 1992

Y1 - 1992

UR - http://www.scopus.com/inward/record.url?scp=0026718112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026718112&partnerID=8YFLogxK

M3 - Article

C2 - 1410859

AN - SCOPUS:0026718112

VL - 12

SP - 315

EP - 324

JO - Seminars in Nephrology

JF - Seminars in Nephrology

SN - 0270-9295

IS - 4

ER -